DUPONT E I DE NEMOURS & CO
10-Q, 1999-05-06
PLASTIC MATERIAL, SYNTH RESIN/RUBBER, CELLULOS (NO GLASS)
Previous: OMNICOM GROUP INC, 424B3, 1999-05-06
Next: EAGLE FOOD CENTERS INC, 10-K/A, 1999-05-06







                                                               


              UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                           WASHINGTON, D.C.  20549
                                  FORM 10-Q


       (X) QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE
                       SECURITIES EXCHANGE ACT OF 1934
                For the quarterly period ended March 31, 1999

                                     OR

       ( ) TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
                       SECURITIES EXCHANGE ACT OF 1934


                        Commission File Number 1-815


                    E. I. du Pont de Nemours and Company
           (Exact Name of Registrant as Specified in Its Charter)


                  Delaware                            51-0014090
       (State or Other Jurisdiction of             (I.R.S. Employer
        Incorporation or Organization)            Identification No.)


               1007 Market Street, Wilmington, Delaware  19898
                  (Address of Principal Executive Offices)


                               (302) 774-1000
                       (Registrant's Telephone Number)


Indicate by check mark whether the registrant (1) has filed all reports 
required to be filed by Section 13 or 15(d) of the Securities Exchange Act 
of 1934 during the preceding 12 months (or for such shorter period that the 
registrant was required to file such reports), and (2) has been subject to 
such filing requirements for the past 90 days.


                           Yes   X         No     


1,127,904,634 shares (excludes 11,609,520 shares held by DuPont's 
Flexitrust) of common stock, $0.30 par value, were outstanding at 
April 30, 1999.
                                                                             




                                      1
<PAGE>

                                                                   Form 10-Q


                   E. I. DU PONT DE NEMOURS AND COMPANY

                             Table of Contents


                                                                     Page(s)
                                                                     -------
Part I  Financial Information
  Item 1.  Financial Statements

    Consolidated Income Statement ...............................       3

    Consolidated Statement of Cash Flows ........................       4

    Consolidated Balance Sheet ..................................       5

    Notes to Financial Statements ...............................      6-11

  Item 2.  Management's Discussion and Analysis of 
           Financial Condition and Results of Operations

    Forward-Looking Statements ..................................     12-13

    Financial Results ...........................................     14-15

    Segment Performance .........................................     15-17

    Financial Condition .........................................     18-19

    Other Items .................................................     20-25

Part II  Other Information
  Item 1.  Legal Proceedings ....................................     25-26

  Item 4.  Submission of Matters to a Vote of Security Holders ..     27-28

  Item 5.  Other Information ....................................     28-29

  Item 6.  Exhibits and Reports on Form 8-K .....................     29-31

Signature .......................................................      32

Exhibit Index ...................................................      33

Exhibit 12 - Computation of Ratio of Earnings to
  Fixed Charges .................................................      34

Exhibit 12-1 - Computation of Ratio of Earnings to
  Fixed Charges - Pro Forma .....................................      35







                                    2
<PAGE>

<TABLE>
                                                                            Form 10-Q
                            PART I.  FINANCIAL STATEMENTS

Item 1.  FINANCIAL STATEMENTS

E. I. DU PONT DE NEMOURS AND COMPANY AND CONSOLIDATED SUBSIDIARIES

<CAPTION>

                                                                Three Months Ended
CONSOLIDATED INCOME STATEMENT<Fa><Fb>                                March 31
- --------------------------------------------------------------------------------------
(Dollars in millions, except per share)                          1999        1998
- -------------------------------------------------------------------------------------
<S>                                                             <C>         <C>
SALES<Fc> ....................................................  $6,295      $6,194
Other Income .................................................      18<Fd>     297
                                                                ------      ------
    Total ....................................................   6,313       6,491
                                                                ------      ------
Cost of Goods Sold and Other Expenses ........................   3,873       4,049
Selling, General and Administrative Expenses .................     535         479
Depreciation and Amortization ................................     335         332
Research and Development .....................................     358         264
Interest Expense .............................................      96         127
Purchased In-Process Research and Development<Fe> ............      40          60
Employee Separation Costs and Write-Down of Assets ...........     -           118<Ff>
                                                                ------      ------
    Total ....................................................   5,237       5,429
                                                                ------      ------
INCOME FROM CONTINUING OPERATIONS BEFORE INCOME TAXES AND
 AND MINORITY INTERESTS ......................................   1,076       1,062
Provision for Income Tax Expenses ............................     432         417
Minority Interests in Earnings of Consolidated Subsidiaries ..      16           8
                                                                ------      ------
INCOME FROM CONTINUING OPERATIONS<Fc> ........................     628         637
DISCONTINUED OPERATIONS
  Income from Operations of Discontinued Business,
    Net of Income Taxes ......................................     -           269
  Gain on Disposal of Discontinued Business,
    Net of Income Taxes ......................................      35         -
                                                                ------      ------
NET INCOME ...................................................  $  663      $  906
                                                                ======      ======
                                                                                     

BASIC EARNINGS PER SHARE OF COMMON STOCK<Fg>
  Continuing Operations ......................................  $  .55      $  .56
  Discontinued Operations ....................................     .04         .24
                                                                ------      ------
  Net Income .................................................  $  .59      $  .80
                                                                ======      ======
DILUTED EARNINGS PER SHARE OF COMMON STOCK<Fg>
  Continuing Operations ......................................  $  .55      $  .55
  Discontinued Operations ....................................     .03         .24
                                                                ------      ------
  Net Income .................................................  $  .58      $  .79      
                                                                ======      ======
DIVIDENDS PER SHARE OF COMMON STOCK ..........................  $  .35      $ .315
                                                                ======      ======
                                                                                     
See Notes to Financial Statements.

</TABLE>
                                          3
<PAGE>

<TABLE>
                                                                                    Form 10-Q 


<CAPTION>

                                                                        Three Months Ended
CONSOLIDATED STATEMENT OF CASH FLOWS<Fa><Fb>                                 March 31
- ---------------------------------------------------------------------------------------------
(Dollars in millions)                                                    1999          1998
- ---------------------------------------------------------------------------------------------
<S>                                                                   <C>            <C>
CASH PROVIDED BY OPERATIONS
  Net Income .....................................................    $   663        $   906
  Adjustments to Reconcile Net Income to Cash
    Provided by Continuing Operations:
      Net Income from Discontinued Operations ....................        (35)          (269)
      Depreciation and Amortization ..............................        335            332
      Purchased In-Process Research and Development ..............         40             60
      Other Noncash Charges and Credits - Net ....................         88            (24)
      Change in Operating Assets and Liabilities - Net ...........       (944)          (853)
                                                                      -------        -------
        Cash Provided by Continuing Operations ...................        147            152
                                                                      -------        -------
INVESTMENT ACTIVITIES
  Purchases of Property, Plant and Equipment .....................       (473)          (465)
  Investment in Affiliates .......................................         (7)           (17)
  Payments for Businesses Acquired (Net of Cash Acquired) ........     (1,656)          (694)
  Proceeds from Sales of Assets ..................................         59            240
  Investments in Short-Term Financial Instruments - Net ..........         (2)           (94)
  Miscellaneous - Net ............................................         (7)           (10)
                                                                      -------        -------
        Cash Used for Investment Activities ......................     (2,086)        (1,040)
                                                                      -------        -------
FINANCING ACTIVITIES
  Dividends Paid to Stockholders .................................       (397)          (358)
  Net Increase in Borrowings .....................................      2,590          2,734
  Acquisition of Treasury Stock ..................................        (44)          (309)
  Proceeds from Exercise of Stock Options ........................         14             36
  Increase in Minority Interests .................................         79            -
                                                                      -------        -------
        Cash Provided by Financing Activities ....................      2,242          2,103
                                                                      -------        -------
Net Cash Flow from Discontinued Operations .......................       (255)          (191)
                                                                      -------        -------
Effect of Exchange Rate Changes on Cash ..........................        (68)            (4)
                                                                      -------        -------
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS .................    $   (20)(h)    $ 1,020
                                                                      =======        =======

                                                                                             


See Notes to Financial Statements.

</TABLE>





                                               4 
<PAGE>

<TABLE>
                                                                                                          Form 10-Q
<CAPTION>

CONSOLIDATED BALANCE SHEET<Fa><Fb>                                                        March 31      December 31
- -------------------------------------------------------------------------------------------------------------------
(Dollars in millions, except per share)                                                     1999           1998
- -------------------------------------------------------------------------------------------------------------------
<S>                                                                                       <C>             <C>
                         ASSETS
CURRENT ASSETS
  Cash and Cash Equivalents ........................................................      $ 1,003         $ 1,059
  Marketable Securities ............................................................           11              10
  Accounts and Notes Receivable ....................................................        5,399           4,201
  Inventories<Fi> ..................................................................        3,566           3,129
  Prepaid Expenses .................................................................          216             192
  Deferred Income Taxes ............................................................          596             645
                                                                                          -------         -------
    Total Current Assets ...........................................................       10,791           9,236
PROPERTY, PLANT AND EQUIPMENT, less accumulated depreciation and amortization
  (March 31, 1999 - $20,652; December 31, 1998 - $20,597) ..........................       14,817          14,131
INVESTMENT IN AFFILIATES ...........................................................        1,801           1,796
OTHER ASSETS .......................................................................        5,908           4,956
NET ASSETS OF DISCONTINUED OPERATIONS<Fj> ..........................................        8,650           8,417
                                                                                          -------         -------
    TOTAL<Fc> ......................................................................       41,967          38,536
                                                                                          =======         =======
          LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES
  Accounts Payable .................................................................        1,900           1,929
  Short-Term Borrowings and Capital Lease Obligations ..............................        9,232           6,629
  Income Taxes .....................................................................          374             130
  Other Accrued Liabilities ........................................................        3,157           2,922
                                                                                          -------         -------
    Total Current Liabilities ......................................................       14,663          11,610
LONG-TERM BORROWINGS AND CAPITAL LEASE OBLIGATIONS .................................        4,566           4,495
OTHER LIABILITIES ..................................................................        7,663           7,640
DEFERRED INCOME TAXES ..............................................................          478             430
                                                                                          -------         -------
    Total Liabilities ..............................................................       27,370          24,175
                                                                                          -------         -------
MINORITY INTERESTS IN CONSOLIDATED SUBSIDIARIES ....................................          464             407
                                                                                          -------         -------
STOCKHOLDERS' EQUITY<Fk>
  Preferred Stock ..................................................................          237             237
  Common Stock, $.30 par value; 1,800,000,000 shares authorized; shares issued 
    at March 31, 1999 - 1,139,514,154; December 31, 1998 - 1,140,354,154 ...........          342             342
  Additional Paid-In Capital .......................................................        7,866           7,854
  Reinvested Earnings ..............................................................        6,933           6,705
  Accumulated Other Comprehensive Loss .............................................         (526)           (432)
  Common Stock Held in Trust for Unearned Employee Compensation and Benefits
    (Flexitrust), at Market (Shares:  March 31, 1999 - 12,379,279; 
    December 31, 1998 - 14,167,867) ................................................         (719)           (752)
                                                                                          -------         -------
    Total Stockholders' Equity .....................................................       14,133          13,954
                                                                                          -------         -------
    TOTAL ..........................................................................      $41,967         $38,536
                                                                                          =======         =======
                                                                                                                   
See Notes to Financial Statements.

</TABLE>

                                                         5 
<PAGE>

                                                                   Form 10-Q



                       NOTES TO FINANCIAL STATEMENTS
                  (Dollars in millions, except per share)


[FN]
<Fa> These statements are unaudited, but reflect all adjustments that, in 
     the opinion of management, are necessary to provide a fair presentation 
     of the financial position, results of operations and cash flows for
     the dates and periods covered.  All such adjustments are of a normal 
     recurring nature.  The company's petroleum business is reported as 
     discontinued operations and is discussed in Notes (b) and (j).

<Fb> Discontinued Operations:
     On September 28, 1998, the company announced that the Board of 
     Directors had approved a plan to divest the company's 100 percent-owned 
     petroleum business (Conoco Inc.).  The company intends to complete the 
     divestiture with a tax-free split off by exchanging its remaining 
     Conoco shares (69.5 percent) for DuPont shares no later than third 
     quarter 1999.  The company has not recognized a deferred tax liability 
     for the difference between the book basis and tax basis of its 
     investment in Conoco's common stock because the company does not expect 
     this basis difference to become subject to tax.  The company's 
     consolidated financial statements and notes report its petroleum 
     business as discontinued operations.  Prior periods have been restated.  
     Results reported separately by Conoco are reported on a stand-alone 
     basis and may differ from results based on discontinued operations 
     reporting.  In addition, beginning October 22, 1998, the company's 
     results from discontinued operations reflect minority interests of 
     30.5 percent.










                                      6
<PAGE>

<TABLE>
                                                                 Form 10-Q

                       NOTES TO FINANCIAL STATEMENTS
                  (Dollars in millions, except per share)
                                 (Continued)
<FN>
<CAPTION>

<Fc> CONSOLIDATED SEGMENT INFORMATION -               Three Months Ended
     CONTINUING OPERATIONS                                 March 31
     -----------------------------------------------------------------------
     (Dollars in millions)                            1999          1998
     ----------------------------------------------------------------------
     <S>                                           <C>            <C>
     SEGMENT SALES<F1>
     -------------
     Agriculture & Nutrition .................     $  780         $  770
     Nylon Enterprise ........................      1,103          1,173
     Performance Coatings & Polymers .........      1,158          1,157
     Pharmaceuticals<F2> .....................        409            217
     Pigments & Chemicals ....................        866            920
     Polyester Enterprise ....................        624            734
     Specialty Fibers ........................        863            851
     Specialty Polymers ......................      1,002          1,034
     Other ...................................         94            164
                                                   ------         ------
         Total Segment Sales .................     $6,899         $7,020

     Elimination of Intersegment Transfers ...       (173)          (204)
     Elimination of Equity Affiliate Sales ...       (431)          (622)
                                                   ------         ------
         SALES ...............................     $6,295         $6,194
                                                   ======         ======
     AFTER-TAX OPERATING INCOME (LOSS)
     ---------------------------------
     Agriculture & Nutrition .................     $   91         $   29<F3>
     Nylon Enterprise ........................        102              5<F4>
     Performance Coatings & Polymers .........        100 <F5>       122
     Pharmaceuticals .........................         75             50
     Pigments & Chemicals ....................        146            157
     Polyester Enterprise ....................         (6)             4
     Specialty Fibers ........................        181            188
     Specialty Polymers ......................        164            158
     Other ...................................         10             45
                                                   ------         ------
         Total Segment ATOI ..................        863            758

     Interest & Exchange Gains (Losses) ......       (163)<F6>       (70)
     Corporate Expenses ......................        (72)           (51)
                                                   ------         ------
         INCOME FROM CONTINUING OPERATIONS ...     $  628         $  637
                                                   ======         ======

                                                   March 31     December 31
     SIGNIFICANT CHANGES IN SEGMENT ASSETS           1999           1998
     -------------------------------------         --------     -----------
     Performance Coatings & Polymers .........      $4,195<F7>     $2,214
                                                    ======         ======
</TABLE>

                                     7
<PAGE>

                                                                    Form 10-Q



                       NOTES TO FINANCIAL STATEMENTS
                  (Dollars in millions, except per share)
                                 (Continued)


[FN]
Footnotes to Note (c)
- ---------------------

<F1> Includes pro rata equity affiliate sales and intersegment transfers.

<F2> The increase in sales reflects the current 100 percent ownership of the 
     pharmaceuticals business versus 50 percent in 1998.  In addition, 
     effective first quarter 1999, revenues from contract manufacturing are 
     reclassified from Other Income to Sales, and prior periods have been 
     restated.  These revenues are $27 and $15 for 1999 and 1998, 
     respectively.

<F3> Includes a charge of $60 for revision, based on independent appraisals, 
     of the purchase price allocation in conjunction with the purchase of 
     Protein Technologies International, related to the value assigned to 
     research and development in progress at the time of purchase for which 
     technological feasibility has not yet been established and no alternative 
     future use is anticipated.

<F4> Includes a charge of $85 related to rationalization of global Nylon 
     operations, principally shutdown of certain manufacturing facilities and 
     employee separation costs.

<F5> Includes an estimated charge of $40 based on preliminary purchase price 
     allocations in conjunction with the purchase of Herberts, the automotive 
     coatings business of Hoechst AG, related to the value assigned to 
     research and development in progress at the time of purchase for which 
     technological feasibility has not yet been established and no alternative 
     future use is anticipated.

<F6> Includes an exchange loss of $81 on forward exchange contracts purchased 
     in 1998 to fix in U.S. dollars the cash required to acquire Herberts, the 
     automotive coatings business of Hoechst AG.  The purchase price for 
     Herberts was negotiated in German marks.

<F7> The change is primarily the result of the purchase of Herberts, the 
     automotive coatings business of Hoechst AG, in February 1999.




                                       8
<PAGE>

                                                                    Form 10-Q



                       NOTES TO FINANCIAL STATEMENTS
                  (Dollars in millions, except per share)
                                 (Continued)


[FN]
<Fd> Includes an exchange loss of $131 on forward exchange contracts pur- 
     chased in 1998 to fix in U.S. dollars the cash required to acquire 
     Herberts, the automotive coatings business of Hoechst AG.  The purchase 
     price for Herberts was negotiated in German marks.

<Fe> Purchased in-process research and development represents the value 
     assigned in a purchase business combination to research and develop- 
     ment projects of the acquired business that were in progress at time 
     of purchase for which technological feasibility has not yet been 
     established and no alternative future use is anticipated.

     In this regard, an estimated charge was recorded in the first quarter 
     1999 in conjunction with the purchase of Herberts, the automotive 
     coatings business of Hoechst AG, based on preliminary allocations of 
     purchase price that are subject to revision.

     First quarter 1998 represents a charge for revision, based on independ- 
     ent appraisals, of the purchase price allocation in conjunction with 
     the purchase of Protein Technologies International.  The charge was not 
     tax effected because this transaction was a stock acquisition rather 
     than an asset purchase.

<Ff> Represents $40 of employee separation costs within the Nylon business 
     and $78 for the shutdown of related manufacturing facilities.

<Fg> Basic earnings per share is computed by dividing income available to 
     common stockholders (the numerator) by the weighted-average number of 
     common shares (the denominator) for the period.  The numerator for both 
     income from continuing operations and net income is reduced by 
     preferred dividends of $2.5.  For diluted earnings per share, the 
     numerator is adjusted to recognize reduced share of earnings assuming 
     options in subsidiary company stock are exercised if the effect of this 
     adjustment is dilutive.  The denominator is based on the following 
     weighted-average number of common shares and includes the additional 
     common shares that would have been outstanding if potentially dilutive 
     common shares had been issued:

                                 Three Months Ended
                                      March 31
                           -------------------------------
                               Basic            Diluted
                           -------------     -------------
                  1999     1,127,086,632     1,138,090,171
                  1998     1,128,415,102     1,145,674,145





                                      9
<PAGE>

                                                                   Form 10-Q



                       NOTES TO FINANCIAL STATEMENTS
                  (Dollars in millions, except per share)
                                 (Continued)

[FN]
     The difference between basic and diluted weighted-average common shares 
     outstanding results from the assumption that dilutive stock options 
     outstanding were exercised.

     The following number of stock options are antidilutive, and therefore 
     are not included in the diluted earnings per share calculation since the 
     exercise price is greater than the average market price:

                                           March 31
                                    -----------------------
                                      1999          1998
                                    ---------     ---------

                  Stock Options     8,576,345     4,998,517

     Compensation expense recognized in income for stock-based employee 
     compensation awards was $7 and $34 for the three months ended March 31, 
     1999 and 1998, respectively.

     Shares held by the Flexitrust are not considered outstanding in comput- 
     ing the foregoing weighted-average number of common shares.

<Fh> Includes the change in cash and cash equivalents classified in the 
     Consolidated Balance Sheet within "Net Assets of Discontinued 
     Operations."

                                                    March 31    December 31
<Fi> Inventories                                      1999         1998
     -----------                                    --------    -----------
     Finished Products .........................    $ 2,567       $ 2,209
     Semifinished Products .....................        826           836
     Raw Materials and Supplies ................        846           749
                                                    -------       -------
                                                      4,239         3,794
     Less:  Adjustment of Inventories to a
       Last-In, First-Out (LIFO) Basis .........        673           665
                                                    -------       -------
         Total .................................    $ 3,566       $ 3,129
                                                    =======       =======











                                     10
<PAGE>

                                                                   Form 10-Q



                       NOTES TO FINANCIAL STATEMENTS
                  (Dollars in millions, except per share)
                                 (Continued)


[FN]
                                                    March 31    December 31
<Fj> Net Assets of Discontinued Operations            1999         1998
     -------------------------------------          --------    -----------
     Cash and Cash Equivalents .................    $   411       $   375
     Other Current Assets ......................      2,885         2,864
     Property, Plant and Equipment - Net .......     11,254        11,438
     Other Assets ..............................      2,102         2,011
     Current Liabilities .......................     (2,404)       (2,473)
     Other Liabilities .........................     (3,898)       (4,115)
     Minority Interests ........................     (1,700)       (1,683)
                                                    -------       -------
       Net Assets of Discontinued Operations ...    $ 8,650       $ 8,417
                                                    =======       =======

<Fk> The following sets forth the company's total comprehensive income for 
     the periods shown:
                                                         Three Months Ended
                                                              March 31
                                                         ------------------
                                                         1999         1998
                                                         -----        -----
     Net Income ................................         $663         $906
     Other Comprehensive Loss, Net of Tax ......          (94)         (20)
                                                         ----         ----
     Total Comprehensive Income ................         $569         $886
                                                         ====         ====









                                     11
<PAGE>

                                                                   Form 10-Q



Item 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL
           CONDITION AND RESULTS OF OPERATIONS

         Forward-Looking Statements
         --------------------------
                 This report contains forward-looking statements which may 
         be identified by their use of words like "plans," "expects," 
         "will," "anticipates," "intends," "projects," "estimates" or other 
         words of similar meaning.  All statements that address expectations 
         or projections about the future, including statements about the 
         company's strategy for growth, product development, market 
         position, expenditures, financial results and the company's efforts 
         to remediate Year 2000 issues, are forward-looking statements.

                 Forward-looking statements are based on certain assumptions 
         and expectations of future events.  The company cannot guarantee 
         that these assumptions and expectations are accurate or will be 
         realized.  In addition to the factors discussed in this report, the 
         following are some of the important factors that could cause the 
         company's actual results to differ materially from those projected 
         in any such forward-looking statements:

              o  The company operates in approximately 65 countries world- 
                 wide and derives about half of its revenues from sales 
                 outside the United States.  Changes in the laws or policies 
                 of other governmental and quasi-governmental activities in 
                 the countries in which the company operates could affect 
                 its business in the country and the company's results of 
                 operations.  In addition, economic factors (including 
                 inflation and fluctuations in interest rates and foreign 
                 currency exchange rates) and competitive factors (such as 
                 greater price competition or a decline in U.S. or European 
                 industry sales from slowing economic growth) in those 
                 countries could affect the company's revenues, expenses and 
                 results.

              o  The company's growth objectives are largely dependent on 
                 its ability to renew its pipeline of new products and to 
                 bring those products to market.  This ability may be 
                 adversely affected by difficulties or delays in product 
                 development including, but not limited to, the inability to 
                 identify viable new products; successfully complete 
                 clinical trials of new pharmaceuticals; obtain relevant 
                 regulatory approvals, which may include approval from the 
                 U.S. Food and Drug Administration; the ability to obtain 
                 adequate intellectual property protection; or gain market 
                 acceptance of the new products.








                                     12
<PAGE>

                                                                   Form 10-Q



              o  As part of its strategy for growth, the company has made 
                 and may continue to make acquisitions, divestitures and 
                 alliances.  There can be no assurance that these will be 
                 completed or beneficial to the company.

              o  The company has articulated and updated in its periodic 
                 reports filed with the Securities and Exchange Commission 
                 on Forms 10-Q and 10-K its timetable and assessment of 
                 costs to become Year 2000-capable.  The failure of the 
                 company or third parties with which it conducts business to 
                 become Year 2000-capable could have a material adverse 
                 affect on the company's financial condition, results of 
                 operation and liquidity.

              o  The company's facilities are subject to a broad array of 
                 environmental laws and regulations.  The costs of complying 
                 with complex environmental laws and regulations as well as 
                 internal voluntary programs, are significant and will con- 
                 tinue to be so for the foreseeable future.  The company's 
                 accruals for such costs and liabilities may not be adequate 
                 since the estimates on which the accruals are based depend 
                 on a number of factors including the nature of the allega- 
                 tion, the complexity of the site, the nature of the remedy, 
                 the outcome of discussions with regulatory agencies and 
                 other potentially responsible parties (PRPs) at multi-party 
                 sites, and the number and financial viability of other 
                 PRPs.

              o  The company's results of operations could be affected by 
                 significant litigation adverse to the company including 
                 product liability claims, patent infringement claims and 
                 antitrust claims.

              o  The profitability of the company's petroleum business 
                 (Conoco Inc.), currently reported as discontinued opera- 
                 tions, will be affected by the prices for crude oil, 
                 natural gas and refined products.  These prices are subject 
                 to wide fluctuations in response to changes in global and 
                 regional supply over which the company has no control, 
                 including political developments and the ability of the 
                 Organization of Petroleum Exporting Countries and other 
                 producing nations to set and maintain production levels and 
                 prices.  The company has announced its intention to com- 
                 pletely divest itself of Conoco no later than the third 
                 quarter of 1999.

                 The foregoing list of important factors does not include 
         all such factors nor necessarily presents them in order of 
         importance. 






                                     13
<PAGE>

                                                                   Form 10-Q



         (a) Results of Operations

             (1) Financial Results:

                 Including discontinued operations and nonrecurring items, 
         diluted earnings per share were $.58 compared to $.79 in 1998.  
         First quarter diluted earnings per share from continuing operations 
         before nonrecurring items of $.66 compare to a first quarter record 
         of $.68 achieved last year.  
         

         Results From Continuing Operations
         ----------------------------------
                 Sales in the quarter were $6.3 billion, up 2 percent from 
         $6.2 billion in the first quarter of 1998.  Volumes, including 
         acquisitions, were up 4 percent while worldwide average prices were 
         down 2 percent, including currency effects.  Excluding acquisi- 
         tions, worldwide volumes were down about 2 percent from the record 
         first quarter of last year.

                 Regionally, U.S. volumes were comparable with last year's 
         first quarter, while prices were down 3 percent, adversely affected 
         by a significant decrease in polyester fiber prices.  In Europe, 
         volumes were down 8 percent while prices were generally flat.  In 
         Asia Pacific, volumes were up 6 percent and prices were down 
         2 percent.

                 Raw material costs were down significantly in the first 
         quarter.  In addition, comparable fixed costs were down 2 percent, 
         and the impact of currency increased sales outside the United 
         States by about 1 percent.  As a result, the total after-tax 
         operating income of the nine business segments achieved the record 
         level set in the first quarter last year.

                 Income from continuing operations for the first quarter 
         1999 was $628 million, compared to $637 million in 1998.  Excluding 
         net charges for nonrecurring items totaling $121 million and 
         $145 million in 1999 and 1998, respectively, underlying income was 
         $749 million versus $782 million in 1998, down 4 percent. 

             In the current quarter nonrecurring items include charges 
         related to the Herberts' acquisition as described in the footnotes 
         on pages 8 and 9.  First quarter 1998 nonrecurring items included a 
         charge for a revision to the estimate for purchased in-process 
         research and development related to the PTI acquisition and a 
         charge for global nylon operations modernization.









                                    14
<PAGE>

                                                                   Form 10-Q



         Results From Discontinued Operations
         ------------------------------------
                 On September 28, 1998, the company announced that the Board 
         of Directors had approved a plan to divest the company's 
         100 percent-owned petroleum business (Conoco Inc.).  The company 
         intends to complete the divestiture with a tax-free split off by 
         exchanging its remaining Conoco shares (69.5 percent) for DuPont 
         shares no later than third quarter 1999.  The company has not 
         recognized a deferred tax liability for the difference between the 
         book basis and tax basis of its investment in Conoco's common stock 
         because the company does not expect this basis difference to become 
         subject to tax.  The company's consolidated financial statements 
         and notes report its petroleum business as discontinued operations.  
         Prior periods have been restated.  Results reported separately by 
         Conoco are reported on a stand-alone basis and may differ from 
         results based on discontinued operations.  In addition, beginning 
         October 22, 1998, the company's results from discontinued 
         operations reflect minority interest of 30.5 percent.  Further 
         discussion of this split off is on page 23.

                 Income from discontinued operations was $35 million com- 
         pared to $269 million, down 87 percent.  Oil production was flat 
         versus first quarter 1998, while gas production increased signifi- 
         cantly.  However, upstream oil and gas prices both declined over 
         20 percent.  This combined with lower downstream prices and margins 
         and the reduction of the company's ownership to 70 percent, 
         resulted in a significant decline in earnings.

             (2) Segment Performance:

                 The following text compares first quarter 1999 results 
         with first quarter 1998, for sales and earnings of each segment, 
         excluding the earnings impact of nonrecurring items described in 
         the footnotes to the "Consolidated Segment Information - 
         Continuing Operations" table at Note (c) on pages 7 and 8.  
         Segment results include intersegment transfers and a pro rata 
         ownership share of the sales and earnings of equity affiliates.  
         Total segment after-tax operating income was $903 million, equal 
         to last year.

              o  Agriculture & Nutrition segment earnings were up 
                 2 percent, as stronger U.S. earnings offset lower results 
                 outside the United States and increase in research and 
                 development.  Segment sales increased 1 percent reflecting 
                 flat prices and a modest volume increase. 










                                    15
<PAGE>

                                                                  Form 10-Q



              o  Nylon Enterprise segment earnings were up 13 percent 
                 principally reflecting increased earnings from carpet 
                 fibers.  Segment sales were down 6 percent including 
                 3 percent lower prices.  The impact of lower prices was 
                 offset by lower raw materials costs and fixed costs.  
                 Total cost productivity improved 4 percent versus the 
                 first quarter 1998.

              o  Performance Coatings & Polymers segment earnings were up 
                 15 percent, principally reflecting better results for 
                 engineering polymers and elastomers.  Herberts' earnings 
                 results are being consolidated one month in arrears and 
                 therefore will first be included in the second quarter.

              o  Pharmaceuticals segment earnings were $75 million compared 
                 with $50 million, up 50 percent.  Segment sales were 
                 $409 million, up 88 percent from $217 million last year.  
                 These results reflect the current 100 percent ownership of 
                 the pharmaceuticals business versus 50 percent last year.  
                 In addition, earnings improvement also reflects higher 
                 income from "Cozaar" antihypertensive, largely offset by 
                 higher research and development expense and goodwill 
                 amortization.

              o  Pigments and Chemicals segment earnings were down 
                 7 percent, reflecting lower earnings in Specialty 
                 Chemicals, partly offset by better results for white 
                 pigments and fluorochemicals.  The earnings decline in 
                 Specialty Chemicals reflects generally lower industrial 
                 chemical volumes and specialty prices as well as the 
                 absence of a gain from the sale of a hydrogen peroxide 
                 plant last year.

              o  Polyester Enterprise segment posted a loss of $6 million 
                 versus earnings of $4 million last year reflecting 
                 15 percent lower sales.  Over capacity and intense price 
                 pressure continue to depress polyester results.  Better 
                 results from resins and intermediates were more than 
                 offset by lower earnings for polyester films and "Dacron" 
                 polyester fiber.  Recently announced ventures with Teijin, 
                 Sabanci Holding and Alpek, discussed on pages 23-25, 
                 should strengthen the company's position in polyester.













                                    16
<PAGE>

                                                                  Form 10-Q



              o  Specialty Fibers segment earnings were down 4 percent, 
                 principally reflecting lower "Lycra" spandex earnings 
                 which were modestly below their record first quarter in 
                 1998.  Earnings from Nonwovens were up on strong U.S. 
                 sales of "Tyvek" and "Sontara".  Segment sales were up 
                 1 percent.

              o  Specialty Polymers segment earnings were 4 percent higher 
                 principally reflecting strength in the Photopolymers & 
                 Electronic Materials.

              o  The Other segment earnings were $10 million versus 
                 $45 million last year, principally reflecting the absence 
                 of earnings from the company's interest in coal which has 
                 been substantially divested.  Partly offsetting was a gain 
                 on the sale of shares of DuPont Photomasks, Inc.













                                    17
<PAGE>

                                                                  Form 10-Q



         (b) Financial Condition at March 31, 1999

         First quarter 1999 cash provided by continuing operations of 
$147 million was comparable with the $152 million generated in the first 
quarter of 1998.  Income from continuing operations of $628 million in 1999 
was in line with $637 million from 1998.  Noncash charges for depreciation 
and amortization and for the write-off of purchased in-processed R&D were 
comparable quarter to quarter.  Other noncash charges and credits - net were 
higher in 1999 primarily reflecting the absence of the timing difference 
between affiliate income and dividends for DuPont Merck Pharmaceuticals.  
Net operating assets and liabilities increased $944 million in 1999 as 
compared to a $853 million increase in 1998, reflecting a typical pattern of 
seasonal working capital builds in a number of business units.  Seasonal 
increases in working capital are usually reversed by year end.

         First quarter 1999 capital investments for purchases of property, 
plant, and equipment and investments in affiliates were $480 million, as 
compared to $482 million spent in 1998.  Payments for businesses acquired in 
1999 totaled $1.7 billion and reflect a cash outlay of $1.6 billion in 
February for the acquisition of Herberts, the automotive coatings business 
of Hoechst AG.  The purchase price also included the assumption of 
$0.2 billion in Herbert's debt.  This acquisition makes DuPont Performance 
Coatings the world's third largest coatings business and the largest 
automotive coatings supplier with sales approaching $4 billion.  First 
quarter 1998 payments for businesses acquired include $0.7 billion for 
acquisition of ICI's polyester films business.

         In March, DuPont announced agreement with Pioneer Hi-Bred 
International, Inc. of Des Moines, Iowa, for a cash and stock merger valued 
at $7.7 billion.  The company's estimated cash outlay to complete the 
acquisition will be $3.5 billion, and is expected in the third quarter of 
1999.  DuPont currently has a 20 percent interest in Pioneer, and after the 
purchase will own 100 percent.  Pioneer is the world's largest seed company 
and is a leader in North America and other key markets.  Further discussion 
of this acquisition is on page 22.

         Proceeds from sales of assets in the first quarter of 1999 totaled 
$59 million, and included the sale of several small operating assets as well 
as office real estate assets.  Proceeds from sales of assets in the first 
quarter of 1998 totaled $240 million, and included the sale of certain 
hydrogen peroxide properties for $150 million, and proceeds related to the 
sale of the Printing and Publishing business totaling $86 million.

         During the quarter, the company spent $44 million to purchase and 
retire 840,000 shares of DuPont common stock.  These purchases were part of 
the program initiated in 1997 to purchase and retire up to 20 million shares 
of DuPont common stock to offset dilution from shares issued under compen- 
sation programs.  In first quarter 1998, the company spent $374 million to 







                                     18
<PAGE>

                                                                  Form 10-Q



purchase and retire 6 million shares in a private placement transaction.  
Not related to the shares buyback program, the company received $65 million 
as a final settlement payment associated with 16 million shares repurchased 
in a private placement transaction in December 1997.

         Increase in minority interests in 1999 reflects $79 million for 
sale of an approximate 14 percent interest in the DuPont Photomasks, Inc. 
business, further reducing DuPont's ownership to approximately 55 percent.

         Total debt, including capital lease obligations and debt assumed in 
acquisitions, at March 31, 1999, was $13.8 billion as compared to 
$11.1 billion at year-end 1998.  The $2.7 billion increase in total debt 
reflects primarily the issuance of commercial paper.  These funds were used 
to finance the $0.9 billion increase in operating assets and liabilities, 
and the Herberts acquisition cash outlay of $1.6 billion.

         On April 20, 1999, Conoco paid $4.0 billion in partial payment of 
its outstanding debt owed to DuPont with funds obtained through third-party 
debt offerings in the month.  The third-party debt obtained by Conoco is not 
guaranteed by DuPont, and this will result in a decrease in Net Assets of 
Discontinued Operations.  DuPont intends to use this payment for general 
corporate purposes, including reduction of debt.

     Certain Statistics - Continuing Operations
     ------------------------------------------
                                           At 3/31/99      At 12/31/98
                                           ----------      -----------
     Cash Flow to Total Debt
       (previous 12 months cash
       provided by operations to
       total debt) ..................           30%             37%

     Current Ratio (current assets
       to current liabilities) ......        0.7:1           0.8:1

     Earnings to Fixed Charges ......          5.8             3.3

     Earnings to Fixed Charges -
       Pro Forma*....................          8.4             4.5

     ------------------
     *Pro Forma statistics exclude interest and debt expense
        which has been allocated to discontinued operations.

         The Cash Flow to Total Debt ratio was down in first quarter 1999 
versus year-end primarily due to the $2.7 billion increase in total debt.  
Days' sales outstanding averaged 59 days in the first quarter, an increase 
of 5 days from fourth quarter 1998, and up 2 days from the first quarter of 
1998. 






                                     19
<PAGE>

                                                                   Form 10-Q



         (c) Other Items

     Year 2000
     ---------
         This is an update on the status of the company's program to become 
Year 2000-capable, and should be read in conjunction with the Year 2000 
Readiness Disclosure in the company's 1998 annual report on Form 10-K.

         Project reporting data indicates that approximately 94 percent of 
the company's critical and significant computer systems are now Year 2000- 
capable, and the remaining systems in these categories are expected to be 
remediated on the following schedule:

                                                               Status As Of
                 Systems                       Time Frame        3/31/99
                 -------                      ------------     ------------
Telecommunications ......................     11/98 - 3/99      Completed*

Mainframe Corporate Data Centers ........         4/99             98%**

Mid-Range Computers .....................     10/98 - 6/99         61%**

Corporate
  (e.g., Payroll and Electronic Mail) ...      1/99 - 6/99         90%**

Business
  (e.g., Inventory Processing) ..........     12/98 - 4Q99         82%**

Manufacturing, Process Control and
  Equipment .............................      4Q98 - 4Q99         94%**


- -----------------------
 *"Completed" means that the remediation phase is substantially completed 
  for systems in the indicated category.  Continuous monitoring is 
  necessary, and therefore, further remediation may be required because of 
  system updates.
**The percent represents the percent of systems which have been remediated
  in the indicated category as measured by the businesses and functional 
  units.


         The company is continuing its Business Partner 2000 Program with 
key suppliers and major customers.  The company has substantially completed 
its survey of key suppliers and as of the end of the first quarter of 1999, 
assessed approximately 23% of its key suppliers as having a high risk of not 
becoming Year 2000-capable on a timely basis.








                                     20
<PAGE>

                                                                 Form 10-Q



         The company continued its survey of its major customers focusing on 
their Year 2000-capability as it affects ordering procedures for, as well as 
delivery of and payment for DuPont products.  Based on responses from 
55 percent of its major customers, the company assessed approximately 
33 percent of them as being in the high risk category as of the end of the 
first quarter 1999 versus 28 percent as of December 31, 1998.  This change 
results from an increase in the number of surveys conducted of major 
customers from Asia Pacific and South America.  However, the company is 
working with its major customers and key suppliers to reduce the risk that 
they will not become Year 2000-capable on a timely basis.  If this risk 
cannot be reduced to the company's satisfaction, appropriate contingency 
plan will be developed by the end of June 1999.

         In February 1999, the company acquired Herberts, a leading supplier 
of automotive coatings in Europe, from Hoechst A.G.  Prior to its acquisi- 
tion by the company, Herberts had initiated a program to become Year 
2000-capable.  Herberts has remediated certain systems, but has yet to 
assess others.

     Since Herberts' Year 2000 Program is configured differently from the 
company's, Herberts' systems are not included in the foregoing remediation 
timetable.  However, the company is working with Herberts to integrate them 
into its Year 2000 Program.  The company's Year 2000 Program for Herberts 
focuses on remediating Herberts' critical manufacturing and process control 
systems as well as related equipment.  In addition, all other critical and 
significant internal Herberts' systems will be remediated.  The company 
believes that as a result of these efforts, the foregoing internal Herberts' 
systems will be Year 2000-capable on a timely basis.  A Project Management 
Office has been established to lead Herberts' Year 2000 Program in Europe 
and Asia Pacific.  Herberts' Year 2000 efforts in Mexico, South America and 
the United States will be lead by the company's existing Project Management 
Office.  A plan has been developed to identify key suppliers to Herberts 
which are not already part of the company's Business Partner 2000 Program.  
Finally, a contingency planning test case will be implemented at certain 
Herberts' manufacturing sites.

     Excluding Herberts, the company continues to expect total expenditures 
to become Year 2000-capable to be in the range of $350 million to 
$400 million, of which 20 percent represents internal costs.  As of 
March 31, 1999, the company had spent an estimated $225 million on imple- 
menting its plan.  The company has not yet estimated the total expenditures 
required for Herberts to become Year 2000-capable, however, the company's 
current expectation is that Herberts' estimated total expenditures will not 
have a material adverse impact on the company.  The company does not 
specifically track all costs associated with employees working on Year 2000 
projects, but has included an estimate of these costs in the amount of 
internal costs included in the range above.  The company does not include 
the costs of systems projects which will address the Year 2000 problem but 







                                     21
<PAGE>

                                                                 Form 10-Q



were initiated to accomplish other (non-Year 2000) objectives.  The company 
will fund Year 2000 expenditures from company cash flow from operations and 
expects that total remediation costs, including those required for Herberts 
and the reallocation of internal resources, will not have a material adverse 
effect on the company's financial condition, results of operations or 
liquidity.

     The foregoing timetable and assessment of costs to become Year 2000- 
capable reflect management's best estimates.  These estimates are based upon 
many assumptions, including:  assumptions about the cost, availability and 
ability of resources to identify and classify systems properly; properly 
identifying them as needing remediation; locating, remediating and modifying 
affected systems; and making various assessments of Year 2000 readiness of 
key third parties and Herberts.  Based upon its activities to date, the 
company does not believe that these factors will cause its current cost and 
timetable projections to differ significantly from those estimated.  How- 
ever, the company cannot reasonably estimate the potential impact on its 
financial condition, results of operations or liquidity if critical third 
parties, including suppliers, customers and governments, do not become Year 
2000-capable on a timely basis.

     Other Activities
     ----------------
       Pioneer Hi-Bred International, Inc.
       -----------------------------------
         In March, DuPont and Pioneer Hi-Bred International, Inc. executed a 
definitive agreement for a stock and cash merger that will result in the 
company's complete ownership of Pioneer.  The company currently has a 
20 percent equity interest in Pioneer.  Under the terms of the agreement, 
Pioneer shareholders will receive $40.00 per share, with 45 percent of the 
shares to be exchanged for cash and 55 percent of the shares receiving 
DuPont common stock.  The total equity value of the transaction is estimated 
to be approximately $7.7 billion for the 80 percent of Pioneer not currently 
owned by DuPont.  Pioneer shareholders will have certain rights to elect 
which form of consideration they will receive.  The merger is expected to 
close during the third quarter of 1999 subject to approval of relevant 
regulatory agencies and Pioneer's shareholders.

       Life Science Alliances and Tracking Stock 
       -----------------------------------------
         In March, the company announced that it is actively seeking 
alliances with other strong partners in the pharmaceuticals industry.  The 
company expects to conclude one or more of these alliances by the end of 
1999.  In addition, the company announced that its board of directors 
authorized actions toward the creation and issuance of a tracking stock for 
its life sciences businesses, i.e., the Agriculture & Nutrition and 
Pharmaceuticals segments.  The creation and issuance of tracking stock 
require the company to file a registration statement with the Securities and 
Exchange Commission and obtain DuPont shareholder approval.  It is antici- 
pated that shareholder approval will be sought in the first half of 2000.





                                     22
<PAGE>

                                                                 Form 10-Q



       Conoco Split-Off
       ----------------
         In March, DuPont received a favorable ruling from the Internal 
Revenue Service that the proposed split-off of Conoco Inc. will be tax free, 
a key condition to completing the exchange offer more fully described in the 
registration statement filed with the Securities and Exchange Commission.  
On April 28, 1999, DuPont's board of directors has authorized a split-off 
plan to establish Conoco as a fully independent company.  The split off will 
be achieved through an exchange offer providing DuPont stockholders the 
opportunity to exchange, on a tax-free basis, shares of DuPont common stock 
for shares of Conoco Class B common stock currently held by DuPont.

         The exchange offer remains subject to the registration statement 
being approved by the Securities and Exchange Commission and acceptable 
market conditions.  A registration statement relating to DuPont common stock 
and Conoco Class B common stock has been filed with the Securities and 
Exchange Commission but has not yet become effective.  These securities may 
not be sold nor may offers to buy be accepted prior to the time the 
registration statement becomes effective.  It is currently anticipated that 
the exchange offer will be completed in the third quarter of 1999.

         The offering will be made only by means of a prospectus which will 
contain the specific terms of the transaction and which will be provided to 
DuPont stockholders at the commencement of the exchange offer. 

         This communication shall not constitute an offer to sell or the 
solicitation of an offer to buy nor shall there be any sale of these 
securities in any state in which such offer, solicitation or sale would be 
unlawful prior to registration or qualification under the securities laws of 
any such state.

       Polyester Joint Ventures
       ------------------------
         In February, DuPont and Teijin Limited signed a letter of intent 
to form a global joint venture to produce and sell polyethylene 
terephthalate and polyethylene naphthalate polyester film.  The 50/50 joint 
venture provides DuPont and Teijin with a world-class, integrated global 
platform for supplying differentiated, value-added polyester film products.  
DuPont will also receive cash, reflecting the difference in the agreed-upon 
values of the respective businesses.

         The new venture with Teijin, including combined sales of about 
$1.4 billion and production capacity over 300,000 tons per year, creates a 
global industry leadership position in polyester films.  It provides for the 
flow of technology between the two companies and leverages DuPont's 
strengths in the U.S., Europe and China with Teijin's strengths in Japan and 
Asia Pacific.








                                     23
<PAGE>

                                                                 Form 10-Q



         The venture will operate globally with a single face to the market, 
recognizing and responding to regional market requirements.  Included in the 
venture is the existing Teijin DuPont Films Ltd. joint venture with opera- 
tions in Circleville, Ohio, and Contern, Luxembourg. 

         In April the following activities took place:

           (1) DuPont and Haci Omer Sabanci Holding, A.S., announced their 
               intent to form a joint venture to develop, make, and sell 
               polyester filament, staple, resins, intermediates, and 
               related products for markets throughout the European region, 
               the Middle East and Africa.  The joint venture is expected 
               to begin operations in the fourth quarter 1999, subject to 
               final corporate and appropriate regulatory approvals.  DuPont 
               and Sabanci will be equal partners in the joint venture, 
               which will have revenues of $1 billion annually and employ 
               approximately 4,500 people.

               The joint venture will include DuPont's PTA (pure tere- 
               phthalic acid) and resins businesses at Wilton, U.K., and 
               "Dacron" filament and staple businesses at Pontypool, U.K., 
               and Uentrop, Germany.  Also included will be Sabanci's 
               polyester subsidiary SASA, with its businesses in polyester 
               filament, staple, resins, bottles and DMT (dimethyl 
               terephthalate) based in Adana, and other sites in Turkey and 
               the Sabanci texturizing plant in Garforth, U.K.

               DuPont and Sabanci will form a separate company that will 
               manage this polyester business under a single management 
               team, which will be named shortly.  The vast majority of 
               DuPont and Sabanci employees currently operating the assets 
               and businesses that are part of the joint venture will become 
               employees of the new company.

               The new company will have full access to DuPont polyester 
               technology and brand management resources, including brands 
               such as "Dacron", "Coolmax", "Melinar" and "Laser+".  The new 
               company will develop and apply polyester technology with 
               DuPont's Global Polyester Enterprise that includes polyester 
               intermediates, staple, filament, fiberfill, films, and resin 
               businesses.

           (2) DuPont, Alpek S.A. de C.V., and Teijin Limited, announced 
               their intent to form a joint venture to make and sell 
               polyester filament yarn in the Americas.  The joint venture 
               is expected to begin operations before year-end, subject to 
               appropriate regulatory approvals.








                                     24
<PAGE>

                                                                  Form 10-Q



               DuPont will be a 50 percent partner in the joint venture, 
               with Alpek and Teijin owning the remaining 50 percent.  The 
               joint venture will have more than 850 million pounds of 
               capacity and revenues of approximately $600 million.  It will 
               include all of the polyester polymer, filament, and textured 
               yarn facilities in Monterrey, Mexico, of the Alpek and Teijin 
               existing joint venture.  The DuPont "Dacron" polyester 
               textile filament facilities at its Cape Fear and Kinston 
               production sites in North Carolina also will be included.

           (3) DuPont-Akra Polyester, LLC, a newly-formed company head- 
               quartered in Charlotte, North Carolina, began producing 
               polyester staple fiber for markets primarily in the Americas 
               as part of a separate joint venture between DuPont and Alpek.


                         PART II.  OTHER INFORMATION


Item 1.  LEGAL PROCEEDINGS

     In 1991, DuPont began receiving claims by growers that use of 
"Benlate" 50 DF fungicide had caused crop damage.  Based on the belief that 
"Benlate" 50 DF would be found to be a contributor to the claimed damage, 
DuPont began paying crop damage claims.  In 1992, however, after 18 months 
of extensive research, DuPont scientists concluded that "Benlate" 50 DF was 
not responsible for plant damage reports received since March 1991, and 
concurrent with these research findings, DuPont stopped paying claims.  To 
date, DuPont has been served with more than 750 lawsuits, most by growers 
who allege plant damage from using "Benlate" 50 DF fungicide.  Approximately 
65 crop lawsuits are still pending against the company, as are approximately 
75 additional "Benlate" 50 DF cases based on alleged personal injury, 
alleged securities violations, alleged discovery abuse and fraud, and 
alleged damage to shrimp farming operations.  On February 17, 1999, the 
Florida Third Circuit Court of Appeals reversed a June 1996 personal injury 
verdict of $3,980,000 against DuPont.  Other personal injury cases are 
pending.   In 1997, three putative "Benlate" 50 DF class actions alleging 
crop damage and asserting fraud claims were filed:  one in Florida state 
court on behalf of growers of ornamental plants in Florida; another in 
Hawaii state court on behalf of Hawaii growers; and a third in Alabama state 
court seeking a nationwide class.  The class allegations in Florida have 
been dropped.  The Alabama case received conditional class certification by 
the state court, but that certification has since been vacated.  A consent 
order and settlement recently ended a long running Georgia case wherein 
plaintiffs had accused the Company of discovery abuse during a 1993 
"Benlate" 50 DF crop case.  Under the consent order, DuPont will supply 
$11 million to fund academic chairs at four Georgia law schools and an 
annual symposium on professionalism in the practice of law in Georgia.  The 
settlement also provides for the payment of plaintiffs' attorneys fees.  A 






                                     25
<PAGE>

                                                                  Form 10-Q



securities fraud class action filed in September 1995 by a shareholder in 
federal district court in Florida against the company and the then-Chairman 
is also still pending.  The plaintiff in this case alleges that DuPont made 
false and misleading statements and omissions about "Benlate" 50 DF, with 
the alleged effect of inflating the price of DuPont's stock between June 19, 
1993, and January 27, 1995.  The district court has certified the case as a 
class action.  Discovery is proceeding.  A shareholder derivative action 
filed in Georgia federal district court, alleging that DuPont's Board of 
Directors breached various duties in connection with the "Benlate" 50 DF 
litigation, remains pending.  Certain plaintiffs who have previously settled 
with the company have filed cases alleging fraud and other misconduct 
relating to the litigation and settlement of "Benlate" 50 DF claims.  A 
number of these cases, filed in Florida, Georgia and Hawaii, have been 
dismissed by trial courts.  The Eleventh Circuit Court of Appeals has 
affirmed the dismissal of a number of such cases and has referred others to 
the Florida Supreme Court for resolution of questions of Florida law.  In 
February 1999 the Ninth Circuit Court of Appeals overturned the dismissal of 
one of the Hawaii cases, remanding the case to federal district court.  
Another of the Hawaii cases is on appeal.  DuPont continues to believe that 
"Benlate" 50 DF fungicide did not cause the damages alleged in these cases 
and intends to defend against such allegations in ongoing matters.

     The company's balance sheets reflect accruals for estimated costs 
associated with this matter.  Adverse changes in these estimated costs could 
result in additional future charges.

     On June 30, 1994, the California Department of Toxic Substances 
Control issued to DuPont's Antioch Works in Antioch, California, an 
Enforcement Order alleging violations of state hazardous waste regulations.  
The alleged violations center principally on the status of several tanks at 
the site.  The Order would require DuPont to undertake certain remedial 
activities around the tanks and pay a fine of $200,000.  In March, DuPont 
entered into a Consent Order with the California Department of Justice 
settling this matter.  No penalties or fines were assessed against DuPont.

     On April 3, 1998, the Environmental Protection Agency Region III 
(EPA) filed an Administrative Complaint against the DuPont Belle plant, 
located in West Virginia, in which it alleges violations of the Resource 
Conservation Recovery Act (RCRA) Boiler and Industrial Furnace (BIF) 
Regulations.  The allegations are that DuPont failed to record feed rates 
while burning hazardous waste, failed to inspect the boiler and failed to 
operate the boiler within established feed limits.  EPA has proposed a civil 
penalty of $263,800.  On February 1, 1999, the matter was settled for 
$69,000 in view of prompt voluntary action taken by DuPont and recognition 
by the EPA that a major potential for harm to health or the environment was 
not created.









                                     26
<PAGE>

                                                                  Form 10-Q



Item 4.  SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

         Business transacted at the Annual Meeting:

         A total of 938,815,508 shares of common stock were voted in person 
or by proxy at the annual meeting of stockholders on April 28, or 
82.4 percent of the shares entitled to be voted.  Business was transacted as 
follows:
     1.  ELECTION OF DIRECTORS:  The 12 nominees listed below were elected 
         to serve on the Board of Directors for the ensuing year.  The vote 
         tabulation with respect to each nominee follows:

                                        Votes        Votes Cast Against
                  Director            Cast for          or Withheld
             -------------------     -----------     ------------------
             C. J. Crawford          931,979,412          6,836,096
             L. C. Duemling          931,956,783          6,858,725
             A. W. Dunham            931,874,744          6,940,764
             E. B. du Pont           932,019,089          6,796,419
             C. O. Holliday, Jr.     932,174,993          6,640,515
             L. D. Juliber           932,259,557          6,555,951
             W. K. Reilly            932,214,125          6,601,383
             H. R. Sharp, III        932,009,520          6,805,988
             C. M. Vest              932,363,669          6,451,839
             G. Watanabe             932,077,116          6,738,392
             S. I. Weill             920,492,142         18,323,366
             E. S. Woolard, Jr.      932,140,310          6,675,198

     2.  RATIFICATION OF INDEPENDENT ACCOUNTANTS:  The proposal to ratify 
         the appointment of PricewaterhouseCoopers LLP as independent 
         accountants for 1999 was approved by a vote of 933,041,674 shares 
         for, 5,979,625 shares against, and 3,960,684 abstentions and broker 
         nonvotes.

     3.  ANNUAL MEETING LOCATION:  A stockholder proposal to rotate the 
         company's annual meeting each year to different parts of the 
         country where DuPont has plant locations and/or large concentration 
         of stockholders was defeated by a vote of 716,200,792 shares 
         against, 19,251,868 for, and 203,362,848 abstentions and broker 
         nonvotes.

     4.  EXECUTIVE COMPENSATION:  A stockholder proposal to limit increases 
         in cash compensation of executive officers was defeated by a vote 
         of 701,595,206 shares against, 32,747,443 shares for, and 
         204,472,859 abstentions and broker nonvotes.

     5.  COMMITTEE MEMBERSHIP:  A stockholder proposal that DuPont adopt a 
         policy that Compensation Committee members be independent was 
         defeated by a vote of 495,437,083 shares against, 236,145,656 
         shares for, and 207,232,769 abstentions and broker nonvotes.





                                     27
<PAGE>

                                                                  Form 10-Q



     6.  BOARD COMPOSITION:  A stockholder proposal to commit to a more 
         diverse board was defeated by a vote of 696,579,951 shares against, 
         38,023,541 shares for, and 204,212,016 abstentions and broker 
         nonvotes.


Item 5.  OTHER INFORMATION

         Organization:
         ------------
         Effective May 1, 1999, the following senior leadership changes were 
made to align DuPont's organizational structure with the company's ongoing 
transformation and plans to achieve sustainable growth.

         Three executive vice presidents now serve as chief operating 
officers for their respective business segments.  They are:

      o  Richard R. Goodmanson, former president and chief executive officer 
         of America West Airlines, who joins DuPont as executive vice 
         president and chief operating officer.

         A U.S. citizen, Mr. Goodmanson is a native of Australia and spent 
         his early career in heavy civil construction primarily in Southeast 
         Asia.  Previously he was senior vice president of operations for 
         Frito-lay, Inc. and a principal with McKinsey & Company.  He brings 
         to DuPont a strong results orientation, extensive international 
         experience, and a track record of marketing and operating excel- 
         lence in a variety of industries and markets.

         Mr. Goodmanson has responsibility for the Specialty Fibers business 
         segment; the Performance Coatings & Polymers business segment; 
         Safety Resources; the Global Services Business; and the Asia 
         Pacific Region.

      o  Kurt M. Landgraf, executive vice president, adds the role of chief 
         operating officer.  He continues to lead the Pharmaceuticals 
         business segment and the Agriculture & Nutrition business segment 
         and retains responsibility for the European region.

      o  Dennis H. Reilley, senior vice president, was promoted to executive 
         vice president and chief operating officer.  Mr. Reilley has 
         responsibility for the following business segments:  Pigments & 
         Chemicals; Specialty Polymers; Nylon; and Polyester.

Concurrently:

      William F. Kirk, senior vice president - Agricultural Enterprise, is 
temporarily assigned full time to the critical role of ensuring a smooth 
integration of Pioneer Hi-Bred International into DuPont.  In this capacity, 






                                     28
<PAGE>

                                                                  Form 10-Q



he reports to Charles O. Holliday, Jr., chairman and chief executive 
officer.  The overall Agricultural Enterprise and Pioneer integration 
strategy is led by Messrs. Kirk, Holliday, and Landgraf.

      Cinda A. Hallman, senior vice president, leads a major effort to 
define the new business models associated with the change from a chemicals 
and energy based company to a chemicals, biology and knowledge based 
company.  This includes behavior, know-how, and business processes.  The 
purpose is to expedite the company's drive to a higher value producing 
company.  In the near term this includes how DuPont integrates Pioneer and 
uses tracking stock effectively.  Cinda Hallman reports to Mr. Holliday and 
coordinates with the Office of the Chief Executive in this work.  She 
retains full responsibility for the information technology organization and 
strategy, as well as Y2K and business contingency planning.

      Stacey J. Mobley, senior vice president, adds the role of chief 
administrative officer.  In addition to his current staff responsibilities, 
Stacey has responsibility for the Americas region.

      John W. Himes, vice president - investor relations, corporate plans 
and financial communications, was promoted to senior vice president.

      With these changes, the Office of the Chief Executive expands and 
includes:  Charles O. Holliday, Jr.; Richard R. Goodmanson; Kurt M. 
Landgraf; Dennis H. Reilley; Stacey J. Mobley; Gary M. Pfeiffer, senior vice 
president and chief financial officer; and Joseph A. Miller, senior vice 
president and chief science and technology officer.  


Item 6.  EXHIBITS AND REPORTS ON FORM 8-K

         (a) Exhibits

               The exhibit index filed with this Form 10-Q is on page 33.

         (b) Reports on Form 8-K

               1.  On January 27, 1999, a Current Report on Form 8-K was 
                   filed in connection with Debt Securities that may be 
                   offered on a delayed or continuous basis under its 
                   Registration Statements on Form S-3 (No. 33-53327, 
                   No. 33-61339, and No. 33-60069).  Under Item 7. 
                   "Financial Statements and Exhibits," the Registrant's 
                   Earnings Press Release, dated January 27, 1999, was filed.

               2.  On February 1, 1999, a Current Report on Form 8-K was 
                   filed in connection with Debt and/or Equity Securities 
                   that may be offered on a delayed or continuous basis 







                                     29
<PAGE>

                                                                  Form 10-Q



                   under Registration Statements on form S-3 (No. 33-53327, 
                   No. 33-61339, and No. 33-60069).  Under Item 5. "Other 
                   Events," the Registrant filed the principal agreement 
                   governing the separation of Conoco from DuPont, plus 
                   certain exhibits to that agreement:  the $7.5 billion 
                   note issued by Conoco and the Registration Rights 
                   Agreement.

               3.  On February 4, 1999, a Current Report on Form 8-K was 
                   filed in connection with Debt and/or Equity Securities 
                   that may be offered on a delayed or continuous basis 
                   under Registration Statements on Form S-3 (No. 33-53327, 
                   No. 33-61339, and No. 33-60069).  Under Item 5. "Other 
                   Events," the Registrant filed a press release entitled, 
                   "DuPont and Teijin Announce Plans to Form a Joint Venture 
                   for Their Global Polyester Films Businesses." 

               4.  On March 1, 1999, a Current Report on Form 8-K was filed 
                   in connection with Debt and/or Equity Securities that may 
                   be offered on a delayed or continuous basis under 
                   Registration Statements on Form S-3 (No. 33-53327, 
                   No. 33-61339, and No. 33-60069).  Under Item 5. "Other 
                   Events," the Registrant filed a press release entitled, 
                   "DuPont Announces The Completion of Its Acquisition of 
                   Herberts."

               5.  On March 10, 1999, a Current Report on Form 8-K was filed 
                   in connection with Debt and/or Equity Securities that may 
                   be offered on a delayed or continuous basis under 
                   Registration Statements on Form S-3 (No. 33-53327, 
                   No. 33-61339, and No. 33-60069).  Under Item 5, "Other 
                   Events," the Registrant filed a press release entitled, 
                   "DuPont Takes Steps To Execute Life Sciences Strategy." 

               6.  On March 12, 1999, a Current Report on Form 8-K was filed 
                   in connection with Debt and/or Equity securities that may 
                   be offered on a delayed or continuous basis under 
                   Registration Statements on Form S-3 (No. 33-53327, 
                   No. 33-61339, and No. 33-60069).  Under Item 5, "Other 
                   Events," the Registrant filed a press release announcing 
                   discussions with Pioneer Hi-Bred International, Inc. 
                   regarding a possible business combination.

               7.  On March 15, 1999, a Current Report on Form 8-K was filed 
                   in connection with Debt and/or Equity Securities that may 
                   be offered on a delayed or continuous basis under 
                   Registration Statements on Form S-3 (No. 33-53327, 








                                     30
<PAGE>

                                                                  Form 10-Q



                    No. 33-61339, and No. 33-60069).  Under Item 5, "Other 
                    Events," the Registrant filed a press release entitled, 
                    "DuPont Outlines Sustainable Growth Strategy For 
                    Investors."

               8.   On March 15, 1999, a Current Report on Form 8-K was filed 
                    in connection with Debt and/or Equity Securities that may 
                    be offered on a delayed or continuous basis under 
                    Registration Statements on Form S-3 (No. 33-53327, 
                    No. 33-61339, and No. 33-60069).  Under Item 5, "Other 
                    Events," the Registrant filed a press release entitled, 
                    "DuPont and Pioneer Hi-Bred International, Inc., Sign 
                    Merger Agreement."

                9.  On April 16, 1999, a Current Report on Form 8-K was 
                    filed in connection with Debt and/or Equity Securities 
                    that may be offered on a delayed or continuous basis 
                    under Registration Statements on Form S-3 (No. 33-53327, 
                    No. 33-61339, and No. 33-60069).  Under Item 5, "Other 
                    Events," the Registrant filed Consolidated Industry 
                    Segment Information (Quarterly) of Continuing Operations 
                    for the years ending December 31, 1998 and 1997.

               10.  On April 27, 1999, a Current Report on Form 8-K was 
                    filed in connection with Debt Securities that may be 
                    offered on a delayed or continuous basis under its 
                    Registration Statements on Form S-3 (No. 33-53327, 
                    No. 33-61339, and No. 33-60069).  Under Item 7, 
                    "Financial Statements and Exhibits," the Registrant's 
                    Earnings Press Release, dated April 27, 1999, was filed.









                                     31
<PAGE>

                                                                   Form 10-Q






                                  SIGNATURE



         Pursuant to the requirements of the Securities Exchange Act of 
1934, the registrant has duly caused this report to be signed on its behalf 
by the undersigned, thereunto duly authorized.





                                E. I. DU PONT DE NEMOURS AND COMPANY
                                            (Registrant)


                              Date:            May 6, 1999
                              -----------------------------------------




                              By          /s/ G. M. Pfeiffer
                              -----------------------------------------

                                           G. M. Pfeiffer
                               Senior Vice President - DuPont Finance
                              (As Duly Authorized Officer and Principal
                                  Financial and Accounting Officer)









                                     32
<PAGE>

                                                                  Form 10-Q





                               EXHIBIT INDEX



Exhibit
Number                            Description
- -------                           -----------


 10.1          Company's Agreement and Plan of Merger, dated as of 
               March 15, 1999, by and among the company, Pioneer Hi-Bred 
               International, Inc. and Delta Acquisition Sub, Inc. 
               (incorporated by reference to Exhibit E to the company's 
               Amendment No. 3, dated March 17, 1999, to its Schedule 13D, 
               originally filed on August 18, 1997, which is the company's 
               statement of beneficial ownership of Pioneer Hi-Bred 
               International, Inc.).


   12          Computation of Ratio of Earnings to Fixed Charges.


 12.1          Computation of Ratio of Earnings to Fixed Charges -
               Pro Forma.


   27*         Financial Data Schedule - quarter ended March 31, 1999.






- --------------
*Filed electronically only.






                                    33
<PAGE>

<TABLE>
                                                                                                                     Form 10-Q
                                                                                                                     Exhibit 12



                                              E. I. DU PONT DE NEMOURS AND COMPANY

                                        COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES
                                                      (Dollars in millions)


<CAPTION>
                                                                                          Years Ended December 31
                                                      Three Months Ended   -----------------------------------------------------
                                                        March 31, 1999       1998        1997        1996       1995      1994
                                                      ------------------   ---------   ---------   ---------   -------   -------
<S>                                                   <C>                  <C>         <C>         <C>         <C>       <C>
Income from Continuing Operations Before
  Extraordinary Item ..............................         $  628         $1,648      $1,432      $2,931      $2,858    $2,205
Provision for Income Taxes ........................            432            941       1,354       1,416       1,432     1,164
Minority Interests in Earnings of Consolidated
  Subsidiaries ....................................             16             24          43          40          29        15
Adjustment for Companies Accounted for
  by the Equity Method ............................             (6)           (39)        936<Fa>      82         126       (33)
Capitalized Interest ..............................            (29)          (120)        (80)        (70)        (76)      (83)
Amortization of Capitalized Interest ..............             16             65<Fb>      82<Fb>     127<Fb>      81        77
                                                            ------         ------      ------      ------      ------    ------
                                                             1,057          2,519       3,767       4,526       4,450     3,345
                                                            ------         ------      ------      ------      ------    ------
Fixed Charges:
  Interest and Debt Expense - Continuing
    Operations ....................................             96            520         389         409         449       343
  Interest and Debt Expense - Discontinued
    Operations ....................................             73            304         252         304         308       216
  Capitalized Interest - Continuing Operations ....             29            120          80          70          76        83
  Capitalized Interest - Discontinued
    Operations ....................................              2             78          90          73          95        59
  Rental Expense Representative of Interest
    Factor ........................................             18             71          83          80          80        83
                                                                           
                                                            ------         ------      ------      ------      ------    ------
                                                               218          1,093         894         936       1,008       784
                                                            ------         ------      ------      ------      ------    ------
Total Adjusted Earnings Available for Payment of
  Fixed Charges ...................................         $1,275         $3,612      $4,661      $5,462      $5,458    $4,129
                                                            ======         ======      ======      ======      ======    ======
Number of Times Fixed Charges are Earned ..........            5.8            3.3         5.2         5.8         5.4       5.3
                                                            ======         ======      ======      ======      ======    ======


<FN>
- --------------------------------
<Fa> Includes write-off of Purchased In-Process Research and Development 
     associated with acquisition of 20% interest in Pioneer Hi-Bred 
     International, Inc.
<Fb> Includes write-off of capitalized interest associated with divested 
     businesses.

</TABLE>


                                                               34
<PAGE>

<TABLE>
                                                                                                                    Form 10-Q
                                                                                                                   Exhibit 12.1


                                              E. I. DU PONT DE NEMOURS AND COMPANY

                                                            PRO FORMA

                                        COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES
                                                      (Dollars in millions)

                                       Ratio of earnings to fixed charges on a continuing
                                       operations basis reflecting interest allocations to
                                   Conoco Inc., which is reported as discontinued operations.


<CAPTION>
                                                                                          Years Ended December 31
                                                      Three Months Ended   -----------------------------------------------------
                                                        March 31, 1999       1998        1997        1996       1995      1994
                                                      ------------------   ---------   ---------   ---------   -------   -------
<S>                                                   <C>                  <C>         <C>         <C>         <C>       <C>  
Income from Continuing Operations Before
  Extraordinary Item ..............................         $  628         $1,648      $1,432      $2,931      $2,858    $2,205
Provision for Income Taxes ........................            432            941       1,354       1,416       1,432     1,164
Minority Interests in Earnings of Consolidated
  Subsidiaries ....................................             16             24          43          40          29        15
Adjustment for Companies Accounted for
  by the Equity Method ............................             (6)           (39)        936<Fa>      82         126       (33)
Capitalized Interest ..............................            (29)          (120)        (80)        (70)        (76)      (83)
Amortization of Capitalized Interest ..............             16             65<Fb>      82<Fb>     127<Fb>      81        77
                                                            ------         ------      ------      ------      ------    ------
                                                             1,057          2,519       3,767       4,526       4,450     3,345
                                                            ------         ------      ------      ------      ------    ------
Fixed Charges:
  Interest and Debt Expense<Fc> ...................             96            520         389         409         449       343
  Capitalized Interest ............................             29            120          80          70          76        83
  Rental Expense Representative of Interest
    Factor ........................................             18             71          83          80          80        83
                                                            ------         ------      ------      ------      ------    ------
                                                               143            711         552         559         605       509
                                                            ------         ------      ------      ------      ------    ------
Total Adjusted Earnings Available for Payment of
  Fixed Charges .................................           $1,200         $3,230      $4,319      $5,085      $5,055    $3,854
                                                            ======         ======      ======      ======      ======    ======
Number of Times Fixed Charges are Earned<Fc> ....              8.4            4.5         7.8         9.1         8.4       7.6
                                                            ======         ======      ======      ======      ======    ======

<FN>
- -----------------------------
<Fa> Includes write-off of Purchased In-Process Research and Development
     associated with acquisition of 20% interest in Pioneer Hi-Bred
     International, Inc.
<Fb> Includes write-off of capitalized interest associated with divested
     businesses.
<Fc> Excludes interest and debt expense which has been allocated to
     discontinued operations.

</TABLE>


                                                               35


<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This Schedule Contains Summary Financial Information Extracted From
Form 10-Q For The Quarterly Period Ended March 31, 1999, And Is
Qualified In Its Entirety By Reference To Such Financial Statements
</LEGEND>
<MULTIPLIER> 1,000,000
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               MAR-31-1999
<CASH>                                           1,003
<SECURITIES>                                        11
<RECEIVABLES>                                    5,399<F1>
<ALLOWANCES>                                         0
<INVENTORY>                                      3,566
<CURRENT-ASSETS>                                10,791
<PP&E>                                          35,469
<DEPRECIATION>                                  20,652
<TOTAL-ASSETS>                                  41,967
<CURRENT-LIABILITIES>                           14,663
<BONDS>                                          4,566
                                0
                                        237
<COMMON>                                           342
<OTHER-SE>                                      13,554
<TOTAL-LIABILITY-AND-EQUITY>                    41,967
<SALES>                                          6,295
<TOTAL-REVENUES>                                 6,313
<CGS>                                            3,873<F2>
<TOTAL-COSTS>                                    5,141<F3>
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                  96
<INCOME-PRETAX>                                  1,076
<INCOME-TAX>                                       432
<INCOME-CONTINUING>                                628
<DISCONTINUED>                                      35
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       663
<EPS-PRIMARY>                                      .59
<EPS-DILUTED>                                      .58
<FN>
<F1>Includes Other Accounts In Addition To Notes and Accounts
Receivable-Trade.
<F2>Includes Other Expenses.
<F3>Cost of Goods Sold and Other Expenses; Depreciation and Amortization;
Research and Development; Selling, General and Administrative Expenses;
and Purchased In-Process Research and Development.
</FN>
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission